These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33289022)

  • 61. Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.
    Priest KC; Lovejoy TI; Englander H; Shull S; McCarty D
    J Gen Intern Med; 2020 Aug; 35(8):2365-2374. PubMed ID: 32291723
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17.
    Shen K; Barrette E; Dafny LS
    Health Aff (Millwood); 2020 Jun; 39(6):993-1001. PubMed ID: 32479213
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment utilization among persons with opioid use disorder in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial.
    Auty SG; Barr KD; Frakt AB; Garrido MM; Strombotne KL
    Addiction; 2023 May; 118(5):870-879. PubMed ID: 36495477
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.
    Martin A; Butler K; Chavez T; Herring A; Wakeman S; Hayes BD; Raja A
    West J Emerg Med; 2020 Nov; 21(6):257-263. PubMed ID: 33207174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Attentional bias in opioid users: A systematic review and meta-analysis.
    MacLean RR; Sofuoglu M; Brede E; Robinson C; Waters AJ
    Drug Alcohol Depend; 2018 Oct; 191():270-278. PubMed ID: 30157467
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioid use disorder with chronic pain increases disease burden and service use.
    MacLean RR; Sofuoglu M; Stefanovics E; Rosenheck R
    Psychol Serv; 2023 Feb; 20(1):157-165. PubMed ID: 34968125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment.
    Justesen K; A Hooker S; Sherman MD; Lonergan-Cullum M; Nissly T; Levy R
    J Am Board Fam Med; 2020; 33(6):848-857. PubMed ID: 33219064
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P; Henke RM; Schaefer MB; Lin J; Creedon TB
    Drug Alcohol Depend; 2020 Dec; 217():108261. PubMed ID: 32979735
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
    Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L
    Mol Psychiatry; 2019 Dec; 24(12):1868-1883. PubMed ID: 29934549
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
    Maglione MA; Raaen L; Chen C; Azhar G; Shahidinia N; Shen M; Maksabedian E; Shanman RM; Newberry S; Hempel S
    J Subst Abuse Treat; 2018 Jun; 89():28-51. PubMed ID: 29706172
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder.
    van Reekum EA; Rosic T; Hudson J; Sanger N; Marsh DC; Worster A; Thabane L; Samaan Z
    Biol Sex Differ; 2020 Apr; 11(1):20. PubMed ID: 32326982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Racial/Ethnic Disparities in Opioid Use Disorder and Poisoning Emergency Department Visits in Florida.
    Chen W; Page TF; Sun W
    J Racial Ethn Health Disparities; 2021 Dec; 8(6):1395-1405. PubMed ID: 33140289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder.
    Meshberg-Cohen S; Black AC; DeViva JC; Petrakis IL; Rosen MI
    Addict Behav; 2019 Feb; 89():29-34. PubMed ID: 30243036
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
    Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
    Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.
    Choi NG; DiNitto DM; Marti CN; Choi BY
    Subst Abus; 2019; 40(2):247-255. PubMed ID: 30810503
    [No Abstract]   [Full Text] [Related]  

  • 79. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
    Klein AA; Seppala MD
    J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Personal and Socioeconomic Determinants in Medication-assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
    Grubb LK
    Clin Ther; 2019 Sep; 41(9):1669-1680. PubMed ID: 31462387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.